The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)
Open accessAbstract
Inhibitors of apoptosis (IAPs) are a family of proteins that play a significant role in the control of programmed cell death (PCD). PCD is essential to maintain healthy cell turnover within tissue but also to fight disease or infection. Uninhibited, IAPs can suppress apoptosis and promote cell cycle progression. Therefore, it is unsurprising that cancer cells demonstrate significantly elevated expression levels of IAPs, resulting in improved cell survival, enhanced tumor growth and subsequent metastasis. Therapies to target IAPs in cancer has garnered substantial scientific interest and as resistance to anti-cancer agents becomes more prevalent, targeting IAPs has become an increasingly attractive strategy to re-sensitize cancer cells to chemotherapies, antibody based-therapies and TRAIL therapy. Antagonism strategies to modulate the actions of XIAP, cIAP1/2 and survivin are the central focus of current research and this review highlights advances within this field with particular emphasis upon the development and specificity of second mitochondria-derived activator of caspase (SMAC) mimetics (synthetic analogs of endogenously expressed inhibitors of IAPs SMAC/DIABLO). While we highlight the potential of SMAC mimetics as effective single agent or combinatory therapies to treat cancer we also discuss the likely clinical implications of resistance to SMAC mimetic therapy, occasionally observed in cancer cell lines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Gupta, S. C., Reuter, S., Phromnoi, K., Park, B., Hema, P. S., Nair, M. S., & Aggarwal, B. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.191379 · Cited by 99
RetractedJanzen, D. M., Tiourin, E., Salehi, J. A., Paik, D. Y., Lu, J. N., Pellegrini, M. A., & Memarzadeh, S. (2015) · Nature Communications · doi:10.1038/ncomms8956 · Cited by 72
RetractedSuzuki, A., Obata, S., Hayashida, M., Kawano, H., Nakano, T., & Shiraki, K. (2001) · Nature Medicine · doi:10.1038/83401 · Cited by 16
RetractedApoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836 · cited 1×
“Specifically, checkpoints can fail following an introduction of mutations in apoptotic genes such as p53, or DNArepair genes like Brac1/2 [12].”
BackgroundExtrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
Fulda, S., & Debatin, K.-M. (2006) · Oncogene · doi:10.1038/sj.onc.1209608 · Cited by 2,312 · cited 2×
“This provides cross-talk between the extrinsic and intrinsic pathways, known as the mitochondrial amplification loop [15, 16].”
BackgroundAnalysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I. R., Lu, L., Irvin, D., Black, K. L., & Yu, J. S. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-67 · Cited by 1,790
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676 · cited 1×
“This excessive rate of cell proliferation gives rise to a hypoxic microenvironment and a dysregulation in growth factors, such as vascular endothelial growth factor (VEGF), that promote angiogenesis and genetic adaptations that can permit a tumor to thrive [3].”
BackgroundWhole–genome characterization of chemoresistant ovarian cancer
Patch, A.-M., Christie, E. L., Etemadmoghadam, D., Garsed, D. W., George, J., Fereday, S., Nones, K., Cowin, P., Alsop, K., Bailey, P. J., et al. (2015) · Nature · doi:10.1038/nature14410 · Cited by 1,569
Tamm, I., Wang, Y., Sausville, E. A., Scudiero, D. A., Vigna, N. J., Oltersdorf, T., & Reed, J. C. (1998) · PubMed · Cited by 1,397
Targeting Apoptosis Pathways in Cancer Therapy
Ghobrial, I. M., Witzig, T. E., & Adjei, A. A. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.3.178 · Cited by 1,330
van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.027 · Cited by 1,240
IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis
Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.030 · Cited by 1,218
Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis
Brentnall, M., Rodriguez-Menocal, L., De Guevara, R. L., Cepero, E., & Boise, L. H. (2013) · BMC Cell Biology · doi:10.1186/1471-2121-14-32 · Cited by 1,147
Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
Yin, X.-M., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Roth, K. A., & Korsmeyer, S. J. (1999) · Nature · doi:10.1038/23730 · Cited by 1,004 · cited 1×
“On the other hand, dysregulation of expression of the protein Bid, responsible for cross-talk between the extrinsic and intrinsic apoptotic pathway (activating the mitochondrial amplification loop), has been shown to potentiate apoptotic survival in hepatocytes [21].”
BackgroundAnnunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
TRAIL and apoptosis induction by TNF-family death receptors
Wang, S., & El-Deiry, W. S. (2003) · Oncogene · doi:10.1038/sj.onc.1207232 · Cited by 871
Structural and biochemical basis of apoptotic activation by Smac/DIABLO
Chai, J., Du, C., Wu, J.-W., Kyin, S., Wang, X., & Shi, Y. (2000) · Nature · doi:10.1038/35022514 · Cited by 864
Feoktistova, M., Geserick, P., Kellert, B., Dimitrova, D. P., Langlais, C., Hupe, M., Cain, K., MacFarlane, M., Häcker, G., & Leverkus, M. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.011 · Cited by 860
Tenev, T., Bianchi, K., Darding, M., Broemer, M., Langlais, C., Wallberg, F., Zachariou, A., Lopez, J., MacFarlane, M., Cain, K., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.006 · Cited by 820
Mitochondrial apoptosis: killing cancer using the enemy within
Lopez, J., & Tait, S. W. G. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.85 · Cited by 784
Structural biology of the Bcl-2 family of proteins
Petros, A. M., Olejniczak, E. T., & Fesik, S. W. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.08.012 · Cited by 745
XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome
Rigaud, S., Fondanèche, M.-C., Lambert, N., Pasquier, B., Mateo, V., Soulas, P., Galicier, L., Le Deist, F., Rieux-Laucat, F., Revy, P., et al. (2006) · Nature · doi:10.1038/nature05257 · Cited by 706
Mechanisms of Action of Bcl-2 Family Proteins
Shamas-Din, A., Kale, J., Leber, B., & Andrews, D. W. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008714 · Cited by 705
A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death
Li, L., Thomas, R. M., Suzuki, H., De Brabander, J. K., Wang, X., & Harran, P. G. (2004) · Science · doi:10.1126/science.1098231 · Cited by 656
Cellular Mechanisms Controlling Caspase Activation and Function
Parrish, A. B., Freel, C. D., & Kornbluth, S. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008672 · Cited by 625
Autocrine TNFα Signaling Renders Human Cancer Cells Susceptible to Smac-Mimetic-Induced Apoptosis
Petersen, S. L., Wang, L., Yalcin-Chin, A., Li, L., Peyton, M., Minna, J., Harran, P., & Wang, X. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.029 · Cited by 571
The inhibitors of apoptosis (IAPs) as cancer targets
Hunter, A. M., LaCasse, E. C., & Korneluk, R. G. (2007) · Apoptosis · doi:10.1007/s10495-007-0087-3 · Cited by 565
Lovell, J. F., Billen, L. P., Bindner, S., Shamas-Din, A., Fradin, C., Leber, B., & Andrews, D. W. (2008) · Cell · doi:10.1016/j.cell.2008.11.010 · Cited by 563
IAP-targeted therapies for cancer
LaCasse, E. C., Mahoney, D. J., Cheung, H. H., Plenchette, S., Baird, S., & Korneluk, R. G. (2008) · Oncogene · doi:10.1038/onc.2008.302 · Cited by 524
LeBlanc, H., Lawrence, D., Varfolomeev, E., Totpal, K., Morlan, J., Schow, P., Fong, S., Schwall, R., Sinicropi, D., & Ashkenazi, A. (2002) · Nature Medicine · doi:10.1038/nm0302-274 · Cited by 507
Lavrik, I., Golks, A., & Krammer, P. H. (2005) · Journal of Cell Science · doi:10.1242/jcs.01610 · Cited by 494
XIAP discriminates between type I and type II FAS-induced apoptosis
Jost, P. J., Grabow, S., Gray, D., McKenzie, M. D., Nachbur, U., Huang, D. C. S., Bouillet, P., Thomas, H. E., Borner, C., Silke, J., et al. (2009) · Nature · doi:10.1038/nature08229 · Cited by 482 · cited 1×
“It has been suggested that broadly antagonizing XIAP as a sensitization strategy could lead to healthy hepatocyte death and subsequent liver damage [165].”
Structural Basis of Caspase Inhibition by XIAP
Huang, Y., Park, Y. C., Rich, R. L., Segal, D., Myszka, D. G., & Wu, H. (2001) · Cell · doi:10.1016/s0092-8674(01)00273-2 · Cited by 467
Survivin, a cancer target with an emerging role in normal adult tissues
Fukuda, S., & Pelus, L. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0375 · Cited by 465
Molecular biology of Bax and Bak activation and action
Westphal, D., Dewson, G., Czabotar, P. E., & Kluck, R. M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.12.019 · Cited by 453
Waterhouse, N. J., Goldstein, J. C., von Ahsen, O., Schuler, M., Newmeyer, D. D., & Green, D. R. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.2.319 · Cited by 451
The CASBAH: a searchable database of caspase substrates
Lüthi, A. U., & Martin, S. J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402103 · Cited by 437
Survivin: a unique target for tumor therapy
Garg, H., Suri, P., Gupta, J. C., Talwar, G. P., & Dubey, S. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0326-1 · Cited by 437
Senan, S., Brade, A., Wang, L.-H., Vansteenkiste, J., Dakhil, S., Biesma, B., Martinez Aguillo, M., Aerts, J., Govindan, R., Rubio-Viqueira, B., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.8824 · Cited by 433
ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
Vucic, D., Stennicke, H. R., Pisabarro, M. T., Salvesen, G. S., & Dixit, V. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00781-8 · Cited by 414
Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis
Dohi, T., Beltrami, E., Wall, N. R., Plescia, J., & Altieri, D. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422222 · Cited by 405
Tseng, P.-H., Matsuzawa, A., Zhang, W., Mino, T., Vignali, D. A. A., & Karin, M. (2010) · Nature Immunology · doi:10.1038/ni.1819 · Cited by 387
Die another way – non-apoptotic mechanisms of cell death
Tait, S. W. G., Ichim, G., & Green, D. R. (2014) · Journal of Cell Science · doi:10.1242/jcs.093575 · Cited by 366 · cited 2×
“However, the mechanisms governing the initiation of necroptosis mediated cell death are so far unexplored in vivo and the repercussions of its potential pro-inflammatory nature have not been fully elucidated [34, 35].”
BackgroundSong, Z., Yao, X., & Wu, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300957200 · Cited by 363
Bertrand, M. J. M., Doiron, K., Labbé, K., Korneluk, R. G., Barker, P. A., & Saleh, M. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.011 · Cited by 340
Cancer therapy in the necroptosis era
Su, Z., Yang, Z., Xie, L., DeWitt, J. P., & Chen, Y. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.8 · Cited by 333
Real, P. J., Sierra, A., de Juan, A., Segovia, J. C., Lopez-Vega, J. M., & Fernandez-Luna, J. L. (2002) · Oncogene · doi:10.1038/sj.onc.1206004 · Cited by 321
Differential Inhibition of TRAIL-Mediated DR5-DISC Formation by Decoy Receptors 1 and 2
Mérino, D., Lalaoui, N., Morizot, A., Schneider, P., Solary, E., & Micheau, O. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00520-06 · Cited by 305
Following TRAIL’s path in the immune system
Falschlehner, C., Schaefer, U., & Walczak, H. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03058.x · Cited by 299
Mehrotra, S., Languino, L. R., Raskett, C. M., Mercurio, A. M., Dohi, T., & Altieri, D. C. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.021 · Cited by 291
Rossi, D., Fangazio, M., Rasi, S., Vaisitti, T., Monti, S., Cresta, S., Chiaretti, S., Del Giudice, I., Fabbri, G., Bruscaggin, A., et al. (2012) · Blood · doi:10.1182/blood-2011-12-395673 · Cited by 289
Birc1e is the gene within the Lgn1 locus associated with resistance to Legionella pneumophila
Diez, E., Lee, S.-H., Gauthier, S., Yaraghi, Z., Tremblay, M., Vidal, S., & Gros, P. (2003) · Nature Genetics · doi:10.1038/ng1065 · Cited by 282
Cai, Q., Sun, H., Peng, Y., Lu, J., Nikolovska-Coleska, Z., McEachern, D., Liu, L., Qiu, S., Yang, C.-Y., Miller, R., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101505d · Cited by 272
Singh, T. R., Shankar, S., Chen, X., Asim, M., & Srivastava, R. K. (2003) · PubMed · Cited by 268
Yang, L., Mashima, T., Sato, S., Mochizuki, M., Sakamoto, H., Yamori, T., Oh‐hara, T., & Tsuruo, T. (2003) · PubMed · Cited by 266
Arnt, C. R., Chiorean, M. V., Heldebrant, M. P., Gores, G. J., & Kaufmann, S. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207578200 · Cited by 263
Flygare, J. A., Beresini, M., Budha, N., Chan, H., Chan, I. T., Cheeti, S., Cohen, F., Deshayes, K., Doerner, K., Eckhardt, S. G., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300060k · Cited by 252
Khaled, A. R., Kim, K., Hofmeister, R., Muegge, K., & Durum, S. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14476 · Cited by 250
The mitochondrial voltage-dependent anion channel 1 in tumor cells
Shoshan-Barmatz, V., Ben-Hail, D., Admoni, L., Krelin, Y., & Tripathi, S. S. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.040 · Cited by 247
Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection function
Hao, Y., Sekine, K., Kawabata, A., Nakamura, H., Ishioka, T., Ohata, H., Katayama, R., Hashimoto, C., Zhang, X., Noda, T., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1159 · Cited by 246
Obexer, P., & Ausserlechner, M. J. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00197 · Cited by 244
A Giant Ubiquitin-conjugating Enzyme Related to IAP Apoptosis Inhibitors
Hauser, H.-P., Bardroff, M., Pyrowolakis, G., & Jentsch, S. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.6.1415 · Cited by 243
Defining Characteristics of Types I and II Apoptotic Cells in Response to TRAIL
Özören, N., & El-Deiry, W. S. (2002) · Neoplasia · doi:10.1038/sj.neo.7900270 · Cited by 237
X-linked Inhibitor of Apoptosis Protein (XIAP) Inhibits Caspase-3 and -7 in Distinct Modes
Suzuki, Y., Nakabayashi, Y., Nakata, K., Reed, J. C., & Takahashi, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102415200 · Cited by 235
Hofer-Warbinek, R., Schmid, J. A., Stehlik, C., Binder, B. R., Lipp, J., & de Martin, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910346199 · Cited by 231
The rheostat in the membrane: BCL-2 family proteins and apoptosis
Volkmann, N., Marassi, F. M., Newmeyer, D. D., & Hanein, D. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.153 · Cited by 224
Lu, J., Bai, L., Sun, H., Nikolovska-Coleska, Z., McEachern, D., Qiu, S., Miller, R. S., Yi, H., Shangary, S., Sun, Y., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2655 · Cited by 201
Survivin splice variants regulate the balance between proliferation and cell death
Caldas, H., Jiang, Y., Holloway, M. P., Fangusaro, J., Mahotka, C., Conway, E. M., & Altura, R. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208350 · Cited by 199
Final Stages of Cytokinesis and Midbody Ring Formation Are Controlled by BRUCE
Pohl, C., & Jentsch, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.012 · Cited by 194
Death receptors as targets in cancer
Micheau, O., Shirley, S., & Dufour, F. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12238 · Cited by 189
Benetatos, C. A., Mitsuuchi, Y., Burns, J. M., Neiman, E. M., Condon, S. M., Yu, G., Seipel, M. E., Kapoor, G. S., LaPorte, M. G., Rippin, S. R., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0798 · Cited by 178
McManus, D. C., Lefebvre, C. A., Cherton-Horvat, G., St-Jean, M., Kandimalla, E. R., Agrawal, S., Morris, S. J., Durkin, J. P., & LaCasse, E. C. (2004) · Oncogene · doi:10.1038/sj.onc.1207967 · Cited by 170
Fernandez, J. G., Rodríguez, D. A., Valenzuela, M., Calderón, C. C., Urzúa, U., Munroe, D. J., Rosas, C., David Lemus, A., Díaz‐Valdivia, N., Wright, M. C., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-209 · Cited by 167
Tamm, I., Richter, S., Oltersdorf, D., Creutzig, U., Harbott, J., Scholz, F., Karawajew, L., Ludwig, W.-D., & Wuchter, C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0642 · Cited by 165
Condon, S. M., Mitsuuchi, Y., Deng, Y., LaPorte, M. G., Rippin, S. R., Haimowitz, T., Alexander, M. D., Kumar, P. T., Hendi, M. S., Lee, Y.-H., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500176w · Cited by 164
Degradation of Survivin by the X-linked Inhibitor of Apoptosis (XIAP)-XAF1 Complex
Arora, V., Cheung, H. H., Plenchette, S., Micali, O. C., Liston, P., & Korneluk, R. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700776200 · Cited by 164
Bockbrader, K., Tan, M., & Sun, Y. N. (2005) · Oncogene · doi:10.1038/sj.onc.1208888 · Cited by 161
Overcoming Multidrug Resistance in Cancer: Clinical Studies of P-Glycoprotein Inhibitors
Coley, H. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_15 · Cited by 160
Structure-Based Design of Potent, Conformationally Constrained Smac Mimetics
Sun, H., Nikolovska-Coleska, Z., Yang, C.-Y., Xu, L., Liu, M., Tomita, Y., Pan, H., Yoshioka, Y., Krajewski, K., Roller, P. P., et al. (2004) · Journal of the American Chemical Society · doi:10.1021/ja047438+ · Cited by 159
Triggering caspase-independent cell death to combat cancer
Mathiasen, I. S., & Jäättelä, M. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02328-6 · Cited by 155
Overcoming resistance of cancer cells to apoptosis
Hersey, P., & Zhang, X. D. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10256 · Cited by 149
Augello, C., Caruso, L., Maggioni, M., Donadon, M., Montorsi, M., Santambrogio, R., Torzilli, G., Vaira, V., Pellegrini, C., Roncalli, M. G., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-125 · Cited by 147
Ling, X., Cao, S., Cheng, Q., Keefe, J. T., Rustum, Y. M., & Li, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045571 · Cited by 141
Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond.
Chiou, S., Jones, M. K., & Tarnawski, A. S. (2003) · PubMed · Cited by 137
Allensworth, J. L., Sauer, S. J., Lyerly, H. K., Morse, M. A., & Devi, G. R. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2352-6 · Cited by 130
Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis
Mizutani, Y., Nakanishi, H., Li, Y. Z., Matsubara, H., Yamamoto, K., Sato, N., Shiraishi, T., Nakamura, T., Mikami, K., Okihara, K., et al. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.4.919 · Cited by 129
Rosato, R. R., Almenara, J. A., Coe, S., & Grant, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0598 · Cited by 128
Steinhart, L., Belz, K., & Fulda, S. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.320 · Cited by 124
Schimmer, A. D., Estey, E. H., Borthakur, G. M., Carter, B. Z., Schiller, G. J., Tallman, M. S., Altman, J. K., Karp, J. E., Kassis, J., Hedley, D. W., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.8172 · Cited by 124
Targeting survivin in cancer: the cell-signalling perspective
Kanwar, J. R., Kamalapuram, S. K., & Kanwar, R. K. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.04.001 · Cited by 120
Noonan, A. M., Bunch, K. P., Chen, J., Herrmann, M. A., Lee, J., Kohn, E. C., O'Sullivan, C. C., Jordan, E., Houston, N. D., Takebe, N., et al. (2015) · Cancer · doi:10.1002/cncr.29783 · Cited by 120
XIAP: Cell death regulation meets copper homeostasis
Mufti, A., Burstein, E., & Duckett, C. S. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.01.033 · Cited by 116
cIAP1 Localizes to the Nuclear Compartment and Modulates the Cell Cycle
Samuel, T., Okada, K., Hyer, M. L., Welsh, K., Zapata, J. M., & Reed, J. C. (2005) · Cancer Research · doi:10.1158/0008-5472.210.65.1 · Cited by 115
Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2
Darding, M., Feltham, R., Tenev, T., Bianchi, K., Benetatos, C. A., Silke, J., & Meier, P. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.10 · Cited by 115
Bianchini, M., Levy, E. M., Zucchini, C., Pinsky, V., Macagno, C., Sanctis, P. D., Valvassori, L., Carinci, P., & Mordoh, J. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.1.83 · Cited by 114
Babykutty, S., Priya, P. S., Nandini, R. J., Kumar, M. A. S., Nair, M. S., Srinivas, P., & Gopala, S. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20812 · Cited by 109
The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells
Krepler, C., Chunduru, S. K., Halloran, M. B., He, X., Xiao, M., Vultur, A., Villanueva, J., Mitsuuchi, Y., Neiman, E. M., Benetatos, C. A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2518 · Cited by 109
Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity
Stojanovska, V., Sakkal, S., & Nurgali, K. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00212.2014 · Cited by 108
Laukens, B., Jennewein, C., Schenk, B., Vanlangenakker, N., Schier, A., Cristofanon, S., Zobel, K., Deshayes, K., Vucic, D., Jeremias, I., et al. (2011) · Neoplasia · doi:10.1593/neo.11610 · Cited by 107
Ferreira, C. G., van der Valk, P., Span, S. W., Jonker, J. M., Postmus, P. E., Kruyt, F. A. E., & Giaccone, G. (2001) · Annals of Oncology · doi:10.1023/a:1011167113067 · Cited by 107
Kluger, H. M., McCarthy, M. M., Alvero, A. B., Sznol, M., Ariyan, S., Camp, R. L., Rimm, D. L., & Mor, G. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-6 · Cited by 104
Molecular Cloning of ILP-2, a Novel Member of the Inhibitor of Apoptosis Protein Family
Richter, B. W. M., Mir, S. S., Eiben, L. J., Lewis, J., Reffey, S. B., Frattini, A., Tian, L., Frank, S., Youle, R. J., Nelson, D. L., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4292-4301.2001 · Cited by 103
The porin VDAC2 is the mitochondrial platform for Bax retrotranslocation
Lauterwasser, J., Todt, F., Zerbes, R. M., Nguyen, T. N., Craigen, W. J., Lazarou, M., van der Laan, M., & Edlich, F. (2016) · Scientific Reports · doi:10.1038/srep32994 · Cited by 100
Huang, Y., Yang, X., Xu, T., Kong, Q., Zhang, Y., Shen, Y., Wei, Y., Wang, G., & Chang, K.-J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3525 · Cited by 97
Increased Survivin Expression Confers Chemoresistance to Tumor-Associated Endothelial Cells
Virrey, J. J., Guan, S., Li, W., Schönthal, A. H., Chen, T. C., & Hofman, F. M. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071079 · Cited by 96
Holčı́k, M., Thompson, C. S., Yaraghi, Z., Lefebvre, C. A., MacKenzie, A., & Korneluk, R. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040469797 · Cited by 96
Fukuda, S., Mantel, C., & Pelus, L. M. (2003) · Blood · doi:10.1182/blood-2003-05-1756 · Cited by 94
Wagner, L., Marschall, V., Karl, S., Cristofanon, S., Zobel, K., Deshayes, K., Vucic, D., Debatin, K., & Fulda, S. (2012) · Oncogene · doi:10.1038/onc.2012.108 · Cited by 92
Chessari, G., Buck, I. M., Day, J. E. H., Day, P. J., Iqbal, A., Johnson, C. N., Lewis, E. J., Martins, V., Miller, D., Reader, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00706 · Cited by 90
Gillissen, B. F., Wendt, J., Richter, A., Richter, A. M., Müer, A., Overkamp, T., Gebhardt, N., Preißner, R., Belka, C., Dörken, B., et al. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200912070 · Cited by 84
Liu, J., Zhang, D., Luo, W., Yu, Y., Yu, J., Li, J., Zhang, X., Zhang, B., Chen, J., Wu, X., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.176982 · Cited by 83
Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level
Morizot, A., Mérino, D., Lalaoui, N., Jacquemin, G., Granci, V., Iessi, E., Lanneau, D., Bouyer, F., Solary, É., Chauffert, B., et al. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.144 · Cited by 82
Neuronal Apoptosis-inhibitory Protein Does Not Interact with Smac and Requires ATP to Bind Caspase-9
Davoodi, J., Lin, L., Kelly, J., Liston, P., & MacKenzie, A. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405963200 · Cited by 81
Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL
Cheng, J., Hylander, B. L., Baer, M. R., Chen, X., & Repasky, E. A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0050 · Cited by 75
Lee, T.-J., Jung, E. M., Lee, J. T., Kim, S., Park, J. W., Choi, K. S., & Kwon, T. K. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0426 · Cited by 73
Expression and localization of inhibitor of apoptosis proteins in normal human tissues
Vischioni, B., van der Valk, P., Span, S. W., Kruyt, F. A. E., Rodríguez, J. A., & Giaccone, G. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.09.022 · Cited by 72
Dai, Y., Liu, M., Tang, W., Li, Y., Lian, J., Lawrence, T. S., & Xu, L. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-392 · Cited by 72
Matzinger, O., Viertl, D., Tsoutsou, P. P., Kadi, L., Rigotti, S., Zanna, C., Wiedemann, N., Vozenin, M., Vuagniaux, G., & Bourhis, J. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.05.017 · Cited by 71
Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells
Chen, K., Lin, J., Shiau, C., Tai, W., Liu, C., Yu, H.-C., Chen, P., & Cheng, A. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.04.023 · Cited by 70
LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC
Yang, C., Wang, H., Zhang, B., Chen, Y., Zhang, Y., Sun, X., Xiao, G., Nan, K., Ren, H., & Qin, S. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0435-7 · Cited by 70
Kim, D.-K., Alvarado, C. S., Abramowsky, C. R., Gu, L., Zhou, M., Soe, M.-M., Sullivan, K., George, B. A., Schemankewitz, E., & Findley, H. W. (2005) · Pediatric and Developmental Pathology · doi:10.1007/s10024-005-4108-3 · Cited by 69
Livin and Bcl-2 expression in high-grade osteosarcoma
Nedelcu, T., Kubista, B., Koller, A., Sulzbacher, I., Mosberger, I., Arrich, F., Trieb, K., Kotz, R. I., & Toma, C. D. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0276-z · Cited by 69
Sears, C. R., Cooney, S. A., Chin-Sinex, H., Mendonca, M. S., & Turchi, J. J. (2016) · DNA repair · doi:10.1016/j.dnarep.2016.02.004 · Cited by 63
Brunckhorst, M. K., Lerner, D. L., Wang, S., & Yu, Q. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.20563 · Cited by 62
Carter, B. Z., Mak, D. H. F., Morris, S. J., Borthakur, G. M., Estey, E. H., Byrd, A. L., Konopleva, M. Y., Kantarjian, H. M., & Andreeff, M. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0545-1 · Cited by 62
van Roosmalen, I. A. M., Quax, W. J., & Kruyt, F. A. E. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.010 · Cited by 62
Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling
Hussain, A. R., Shahab Uddin, M. S., Ahmed, M., Bu, R., Ahmed, S. O., Abubaker, J. A., Sultana, M., Ajarim, D. S., Al‐Dayel, F., Bavi, P. P., et al. (2010) · The Journal of Pathology · doi:10.1002/path.2747 · Cited by 61
Esposito, I., Kleeff, J. H., Abiatari, I., Shi, X., Giese, N. A., Bergmann, F., Roth, W., Frieß, H., & Schirmacher, P. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.038257 · Cited by 60
Varfolomeev, E. E., Alicke, B., Elliott, J. M., Zobel, K., West, K. A., Wong, H. H., Scheer, J. M., Ashkenazi, A., Gould, S. E., Fairbrother, W. J., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.040139 · Cited by 58
Gillissen, B. F., Richter, A., Richter, A., Overkamp, T., Eßmann, F., Hemmati, P., Preißner, R., Belka, C., & Daniel, P. T. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.67 · Cited by 55
Dechant, M. J., Fellenberg, J., Scheuerpflug, C. G., Ewerbeck, V., & Debatin, K. (2004) · International Journal of Cancer · doi:10.1002/ijc.20008 · Cited by 55
Tchoghandjian, A., Soubéran, A., Tabouret, É., Colin, C., Denicolaï, E., Jiguet‐Jiglaire, C., Battari, A. E., Villard, C., Baeza, N., & Figarella‐Branger, D. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.214 · Cited by 52
Guicciardi, M. E., Mott, J. L., Bronk, S. F., Kurita, S., Fingas, C. D., & Gores, G. J. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.10.005 · Cited by 51
Belz, K., Schoeneberger, H., Wehner, S., Weigert, A., Bonig, H. B., Klingebiel, T., Fichtner, I., & Fulda, S. (2014) · Blood · doi:10.1182/blood-2013-05-500918 · Cited by 51
Yang, C., Davis, J. L., Zeng, R., Vora, P., Su, X., Collins, L. I., Vangveravong, S., Mach, R. H., Piwnica-Worms, D., Weilbaecher, K. N., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0271 · Cited by 50
Ma, J., Chen, B., & Xin, X. (2009) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2009.06.011 · Cited by 48
Synergistic effects of IAP inhibitor LCL161 and paclitaxel on hepatocellular carcinoma cells
Tian, A., Wilson, G. S., Lie, S., Wu, G. J., Hu, Z., Hebbard, L., Duan, W., George, J., & Qiao, L. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.06.006 · Cited by 47
Zhao, Y., Foster, N. R., Meyers, J. P., Thomas, S. P., Northfelt, D., Rowland, K. M., Mattar, B. I., Johnson, D. B., Molina, J. R., Mandrekar, S. J., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000383 · Cited by 47
Kang, Z., Chen, J., Yu, Y., Li, B., Sun, S., Zhang, B., & Cao, L. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2874 · Cited by 47
Qin, Q., Zuo, Y., Yang, X., Lü, J., Zhan, L., Xu, L., Zhang, C., Zhu, H., Liu, J., Liu, Z., et al. (2013) · Tumor Biology · doi:10.1007/s13277-013-1338-2 · Cited by 46
TRAIL-activated stress kinases suppress apoptosis through transcriptional upregulation of MCL-1
Son, J.-Y., Varadarajan, S., & Bratton, S. B. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.9 · Cited by 46
Venza, I., Visalli, M., Oteri, R., Teti, D. V., & Venza, M. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.05.024 · Cited by 45
BRUCE regulates DNA double-strand break response by promoting USP8 deubiquitination of BRIT1
Ge, C., Che, L., Ren, J., PANDITA, R. K., Lu, J., Li, K., Pandita, T. K., & Du, C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418335112 · Cited by 45
Inhibition of MARCH5 ubiquitin ligase abrogates MCL1-dependent resistance to BH3 mimetics via NOXA
Subramanian, A., Andronache, A., Li, Y., & Wade, M. R. (2016) · Oncotarget · doi:10.18632/oncotarget.7558 · Cited by 44
Mahadevan, D., Chalasani, P., Rensvold, D., Kurtin, S., Pretzinger, C., Jolivet, J., Ramanathan, R. K., Hoff, D. D. V., & Weiss, G. J. (2012) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3182467a13 · Cited by 43
Perimenis, P., Galaris, A., Voulgari, A., Margarita, P., & Pintzas, A. (2016) · BMC Cancer · doi:10.1186/s12885-016-2606-5 · Cited by 40
Knights, A. J., Fucikova, J. P., Pasam, A., Koernig, S., & Cebon, J. S. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1342-1 · Cited by 37
Ortiz-Ferrón, G., Yerbes, R., Eramo, A., López-Pérez, A. I., Maria, R. D., & López‐Rivas, A. (2008) · Cell Research · doi:10.1038/cr.2008.54 · Cited by 36
CLL cells are resistant to smac mimetics because of an inability to form a ripoptosome complex
Maas, C., Tromp, J. M., van Laar, J., Thijssen, R., Elias, J. A., Malara, A., Krippner‐Heidenreich, A., Silke, J., van Oers, M. H. J., & Eldering, E. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.305 · Cited by 34
Estrogen Promotes Breast Cancer Cell Survival in an Inhibitor of Apoptosis (IAP)-dependent Manner
Stanculescu, A., Bembinster, L. A., Borgen, K. R., Bergamaschi, A., Wiley, E. L., & Frasor, J. M. (2010) · Hormones and Cancer · doi:10.1007/s12672-010-0018-6 · Cited by 34
West, A. C., Martin, B. P., Andrews, D. M., Hogg, S. J., Banerjee, A., Grigoriadis, G., Johnstone, R. W., & Shortt, J. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.26 · Cited by 34
Seo, O.-W., Kim, J. H., Lee, K.-S., Lee, K.-S., Kim, J.-H., Won, M., Ha, K., Kwon, Y., & Kim, Y.-M. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.11.074 · Cited by 33
The Opposing Roles of Cellular Inhibitor of Apoptosis Proteins in Cancer
Lau, R., & Pratt, M. A. C. (2012) · ISRN Oncology · doi:10.5402/2012/928120 · Cited by 31
Inability to resolve specific infection generates innate immunodeficiency syndrome in Xiap−/− mice
Hsieh, W., Chuang, Y.-T., Chiang, I., Hsu, S., Miaw, S., & Lai, M. (2014) · Blood · doi:10.1182/blood-2014-03-564609 · Cited by 31
Wang, J., Wang, L., Xia, B., Yang, C., Lai, H., & Chen, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062936 · Cited by 30
Ponnelle, T., Chapusot, C., Martin, L., Bonithon‐Kopp, C., Bouvier, A., Plenchette, S., Rageot, D., Faivre, J., Solary, É., & Piard, F. (2003) · Pathology - Research and Practice · doi:10.1078/0344-0338-00488 · Cited by 30
Molecular Pathways: Targeting Death Receptors and Smac Mimetics
Fulda, S. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2376 · Cited by 30
Tassi, E., Zanon, M., Vegetti, C., Molla, A., Bersani, I., Perotti, V., Pennati, M., Zaffaroni, N., Milella, M., Ferrone, S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2232 · Cited by 29
Yu, C., Wu, P., Hsu, J., Ho, Y., Hsu, L., Chang, Y., Chang, H., Chen, I., & Guh, J. (2012) · The Prostate · doi:10.1002/pros.22548 · Cited by 29
Distribution of Neuronal Apoptosis Inhibitory Protein in Human Tissues
Maier, J. K. X., Balabanian, S., Coffill, C. R., Stewart, A., Pelletier, L., Franks, D. J., Gendron, N. H., & MacKenzie, A. (2007) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.6a7144.2007 · Cited by 28
Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis
Welsh, K., Milutinovic, S., Ardecky, R., González‐López, M., Reddy, S., Teriete, P., Finlay, D., Riedl, S. J., Matsuzawa, S., Pinilla, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161952 · Cited by 27
Schirmer, M., Trentin, L., Queudeville, M., Seyfried, F., Demir, S., Tausch, E., Stilgenbauer, S., Eckhoff, S. M., Meyer, L. H., & Debatin, K. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.382 · Cited by 26
Nathwani, S.-M., Greene, L. M., Butini, S., Campiani, G., Williams, D. C., Samali, A., Szegezdi, É., & Zisterer, D. M. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3518 · Cited by 24
Expression of cIAP-1 correlates with nodal metastasis in squamous cell carcinoma of the tongue
Qi, S., Mogi, S., Tsuda, H., Tanaka, Y., Kozaki, K.-I., Imoto, I., Inazawa, J., Hasegawa, S., & Omura, K. (2008) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2008.06.004 · Cited by 23
Ling, X., & Li, F. (2013) · Europe PMC (PubMed Central) · Cited by 21
Small molecule inhibitor of apoptosis proteins antagonists: a patent review
Hird, A. W., Aquila, B. M., Hennessy, E. J., Vasbinder, M. M., & Yang, B. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1041922 · Cited by 21
cIAP-2 block apoptotic events in bladder cancer cells.
Jönsson, G., Paulie, S., & Grandien, A. (2003) · PubMed · Cited by 19
Beug, S. T., LaCasse, E. C., & Korneluk, R. G. (2014) · OncoImmunology · doi:10.4161/onci.28541 · Cited by 18
Phosphorylation of XIAP by CDK1–cyclin-B1 controls mitotic cell death
Hou, Y., Allan, L. A., & Clarke, P. R. (2016) · Journal of Cell Science · doi:10.1242/jcs.192310 · Cited by 18
Anti-cancer IAP antagonists promote bone metastasis: a cautionary tale
Yang, C., & Novack, D. V. (2013) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-013-0479-0 · Cited by 14
Balakrishnan, K., Fu, M., Onida, F., Wierda, W. G., Keating, M. J., & Gandhi, V. V. (2016) · Oncotarget · doi:10.18632/oncotarget.8462 · Cited by 12
Inhibiting the inhibitors: Retro-inverso Smac peptides
Hossbach, J., Michalsky, E., Henklein, P., Jäger, M., Daniel, P. T., & Preißner, R. (2009) · Peptides · doi:10.1016/j.peptides.2009.08.001 · Cited by 11
Zinonos, I., Labrinidis, A., Liapis, V., Hay, S. J., Panagopoulos, V., DeNichilo, M. O., Ponomarev, V., Ingman, W. V., Atkins, G. J., Findlay, D. M., et al. (2014) · PubMed · Cited by 11
Eckhardt, S. G., Gallant, G., Sikic, B. I., Camidge, D. R., Burris, H. A., Wakelee, H. A., Messersmith, W. A., Jones, S. F., Colevas, A. D., & Infante, J. R. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.2580 · Cited by 11
Cited by
Targeting apoptosis in cancer therapy
Carneiro, B. A., & El-Deiry, W. S. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0341-y · Cited by 2,542
Flavonoids in Cancer and Apoptosis
Abotaleb, M., Samuel, S., Varghese, E., Varghese, S., Kubatka, P., Liskova, A., & Büsselberg, D. (2018) · Cancers · doi:10.3390/cancers11010028 · Cited by 751
Self-citationJežek, J., Cooper, K., & Strich, R. (2018) · Antioxidants · doi:10.3390/antiox7010013 · Cited by 514
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
Neophytou, C. M., Trougakos, I. P., Erin, N., & Papageorgis, P. (2021) · Cancers · doi:10.3390/cancers13174363 · Cited by 371
Understanding and targeting resistance mechanisms in cancer
Lei, Z., Tian, Q., Teng, Q., Wurpel, J. N. D., Zeng, L., Pan, Y., & Chen, Z. (2023) · MedComm · doi:10.1002/mco2.265 · Cited by 347
Metadata
- Authors
- Rathore, R., McCallum, J. E., Varghese, E., Florea, A.-M., & Büsselberg, D.
- Venue
- Apoptosis
- Published
- 2017-04-19
- Volume
- 22
- Issue
- 7
- Pages
- 898-919
- ISSN
- 1360-8185 (ISSN-L)
- 1573-675X
- OpenAlex
- W2605995955
- Cited by
- 277
- References
- 177
- FWCI
- 11.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.